FDA: Comment Period for Draft Guidance Extended to December 2nd
The industry breathed a temporary sigh of relief when they learned that FDA had extended the comment period for its New Dietary Ingredient (NDI) Draft
Follow us on :
The industry breathed a temporary sigh of relief when they learned that FDA had extended the comment period for its New Dietary Ingredient (NDI) Draft
Fax: (516) 294-0477
Email: info@supplementcounsel.com
Address: 138 Mineola Blvd,
Mineola, NY 11501